Search results
FreightTech Friday: Learn to Win raises $30M, captures the industry’s attention
FreightWaves via Yahoo Finance· 2 days agoThis week, training software for the DOD is serving the freight community; CargoSense closes its...
Exploring High Insider Ownership Growth Stocks On Euronext Paris
Simply Wall St. via Yahoo Finance· 6 days agoAmid a backdrop of cautious optimism in European markets, with France's CAC 40 Index showing modest...
Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?
Zacks via Yahoo Finance· 5 days agoDHS's heaviest allocation is in the Financials sector, which is about 24.70% of the portfolio. Its...
10 Best ETFs To Buy and Hold for Long-Term Growth
GoBankingRates via AOL· 4 days agoIf you're a long-term investor looking to diversify your growth portfolio, there are a number of exchange-traded funds that can help you reach your...
Morning Brew: Tesla's Shareholder Votes and Broadcom's Stellar P
Guru Focus· 3 days agoS&P futures are up 5 points, trading 0.1% above fair value. Nasdaq futures are up 117 points,...
DGRO vs. DGRW: Battle of the Dividend Growth ETFs
TipRanks via Yahoo Finance· 5 days agoDividend growth investing has proven to be an attractive investment strategy over time, and there are several strong ETFs that enable investors to invest...
How One Artist Found Relief From His Psoriasis Symptoms
Men's Health via Yahoo News· 6 days agoDaQuane Cherry has been dealing with psoriasis, an autoimmune disease that causes red, flaky skin,...
REGENXBIO appoints new CEO, maintains financial outlook By Investing.com
Investing.com· 4 days agoBiotechnology firm REGENXBIO Inc. (NASDAQ:RGNX) on Wednesday announced a leadership transition, with...
Kristin Chenoweth Opens up About 'Excruciating' Chronic Migraines & the Treatment That Helped
SheKnows via Yahoo News· 5 days agoKristin Chenoweth got her first migraine at age 25, and she remembers it vividly. The Broadway...
Regenxbio CEO to step down after 15 years
BioPharma Dive via Yahoo Finance· 4 days agoKenneth Mills will become chair of the gene therapy developer's board while Curran Simpson, the current chief operating officer, will take his place as...
